Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)
CUSIP: 01438T106
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 59,794,743
- Total 13F shares
- 12,131,183
- Share change
- +1,834,654
- Total reported value
- $96,444,142
- Price per share
- $7.95
- Number of holders
- 65
- Value change
- +$14,632,796
- Number of buys
- 44
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.2%
|
3,085,458
|
$23,141,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,611,311
|
$12,085,000 | — | 31 Mar 2018 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.7%
|
1,009,131
|
$7,568,000 | — | 31 Mar 2018 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.7%
|
1,000,000
|
$7,500,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
753,143
|
$5,649,000 | — | 31 Mar 2018 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
750,000
|
$5,625,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
697,634
|
$5,232,000 | — | 31 Mar 2018 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.54%
|
324,019
|
$2,430,000 | — | 31 Mar 2018 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.21%
|
124,096
|
$931,000 | — | 31 Mar 2018 | |
| Hikari Power Ltd |
13F
|
Company |
0.18%
|
107,858
|
$809,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
102,263
|
$766,000 | — | 31 Mar 2018 | |
| WOODSTOCK CORP |
13F
|
Company |
0.11%
|
67,759
|
$508,000 | — | 31 Mar 2018 | |
| Stanley-Laman Group, Ltd. |
13F
|
Company |
0.11%
|
64,029
|
$480,000 | — | 31 Mar 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.1%
|
62,429
|
$468,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
59,502
|
$446,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
48,151
|
$361,000 | — | 31 Mar 2018 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.08%
|
47,400
|
$356,000 | — | 31 Mar 2018 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.08%
|
45,000
|
$336,000 | — | 31 Mar 2018 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
44,084
|
$331,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
39,407
|
$296,000 | — | 31 Mar 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
30,600
|
$230,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
25,931
|
$194,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
20,791
|
$156,000 | — | 31 Mar 2018 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.03%
|
19,250
|
$145,000 | — | 31 Mar 2018 | |
| ELEMENT CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
16,431
|
$123,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
15,567
|
$117,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
14,796
|
$111,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
14,531
|
$109,000 | — | 31 Mar 2018 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.02%
|
14,371
|
$108,000 | — | 31 Mar 2018 | |
| DRW Securities, LLC |
13F
|
Company |
0.02%
|
12,000
|
$90,000 | — | 31 Mar 2018 | |
| Jefferies Group LLC |
13F
|
Company |
0.02%
|
11,900
|
$89,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
11,250
|
$84,000 | — | 31 Mar 2018 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.02%
|
10,367
|
$79,000 | — | 31 Mar 2018 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
7,918
|
$59,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,441
|
$48,000 | — | 31 Mar 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
4,615
|
$35,000 | — | 31 Mar 2018 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
2,731
|
$20,000 | — | 31 Mar 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,053
|
$8,000 | — | 31 Mar 2018 | |
| Private Ocean, LLC |
13F
|
Company |
0%
|
1,000
|
$7,000 | — | 31 Mar 2018 | |
| PEDDOCK CAPITAL ADVISORS, LLC |
13F
|
Company |
0%
|
752
|
$6,000 | — | 31 Mar 2018 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
250
|
$1,000 | — | 31 Mar 2018 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
139
|
$1,000 | — | 31 Mar 2018 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.